EvaluateMedTech gives you the understanding and time you need to drive better decisions.
Our clients include leading medtech companies and their advisors, as well as businesses that support this sector. They rely on EvaluateMedTech to track, benchmark and forecast the global medical device and diagnostic industry.
We help you quickly analyse the global landscape with consensus forecasts to 2026 for product segment sales, company financials and market share, as well as clinical trial activity, pipeline development, FDA regulatory applications and approvals, Japan PMDA approvals and EU CE Mark approvals.
“ Evaluate is a source you don't have to justify...everybody is in agreement about the accuracy. Not only does this mean we don’t need to do all the work ourselves, but it also saves time because we don't have to debate the numbers. ”
“ Evaluate’s extensive data classifications make it a powerful tool for anyone to easily access information. It contains a detailed search and many of its reports can be personally customised, which makes the platform very user-friendly. ”
Evaluate Omnium is the first and only solution on the market that provides a complete, dynamic view of development risk and commercial return, while also addressing the information gaps that lead to unproductive portfolio investments. The result is 4 times greater accuracy when predicting which Phase I assets will reach the market and a 21% accuracy improvement when predicting commercial potential for Phase I assets, compared to calculations made based on industry average benchmarks.